Tocilizumab, A Humanized Anti-IL-6R Antibody, as an Emerging Therapeutic Option for Rheumatoid Arthritis: Molecular and Cellular Mechanistic Insights
出版年份 2014 全文链接
标题
Tocilizumab, A Humanized Anti-IL-6R Antibody, as an Emerging Therapeutic Option for Rheumatoid Arthritis: Molecular and Cellular Mechanistic Insights
作者
关键词
-
出版物
INTERNATIONAL REVIEWS OF IMMUNOLOGY
Volume 34, Issue 3, Pages 265-279
出版商
Informa UK Limited
发表日期
2014-08-06
DOI
10.3109/08830185.2014.938325
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Therapeutic Targeting of IL-6 Trans Signaling Counteracts STAT3 Control of Experimental Inflammatory Arthritis
- (2014) M. A. Nowell et al. JOURNAL OF IMMUNOLOGY
- Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy
- (2014) Norihiro Nishimoto et al. Modern Rheumatology
- Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
- (2013) Cem Gabay et al. LANCET
- Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis
- (2013) Pauline A. van Schouwenburg et al. Nature Reviews Rheumatology
- Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes
- (2013) Jung-Yoon Choe et al. ARTHRITIS RESEARCH & THERAPY
- Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy
- (2012) Narendra Chirmule et al. AAPS Journal
- Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients in a dose dependent manner
- (2012) Charlotte L Krieckaert et al. ANNALS OF THE RHEUMATIC DISEASES
- Ultrasonographic resolution of the vessel wall oedema with modest clinical improvement in a large-vessel vasculitis patient treated with tocilizumab
- (2012) Emilio Besada et al. CLINICAL RHEUMATOLOGY
- The interleukin-6 pathway and atherosclerosis
- (2012) S Matthijs Boekholdt et al. LANCET
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
- (2012) LANCET
- The pathogenesis of rheumatoid arthritis: new insights from old clinical data?
- (2012) Josef S. Smolen et al. Nature Reviews Rheumatology
- Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE study
- (2012) V. Strand et al. RHEUMATOLOGY
- Interleukin-6 promotes destabilized angiogenesis by modulating angiopoietin expression in rheumatoid arthritis
- (2012) K. Kayakabe et al. RHEUMATOLOGY
- A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis
- (2011) A.D. Protogerou et al. ATHEROSCLEROSIS
- IL-6/IL-6 receptor system and its role in physiological and pathological conditions
- (2011) Masahiko Mihara et al. CLINICAL SCIENCE
- Osteoclast Activity and Subtypes as a Function of Physiology and Pathology—Implications for Future Treatments of Osteoporosis
- (2011) K. Henriksen et al. ENDOCRINE REVIEWS
- Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
- (2011) Simon A. Jones et al. JOURNAL OF CLINICAL INVESTIGATION
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- The incidence of permanent work disability in patients with rheumatoid arthritis in Sweden 1990-2010: before and after introduction of biologic agents
- (2011) E. Hallert et al. RHEUMATOLOGY
- Very early improvements in the wrist and hand assessed by power doppler sonography predicting later favorable responses in tocilizumab-treated patients with rheumatoid arthritis
- (2011) Kensuke Kume et al. ARTHRITIS CARE & RESEARCH
- Meeting report on protein particles and immunogenicity of therapeutic proteins: Filling in the gaps in risk evaluation and mitigation
- (2010) John Carpenter et al. BIOLOGICALS
- Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease
- (2010) S.-N. J. Song et al. BLOOD
- Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
- (2009) G. Jones et al. ANNALS OF THE RHEUMATIC DISEASES
- Atherosclerosis in Rheumatoid Arthritis Versus Diabetes
- (2009) Kimon S. Stamatelopoulos et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Rapid and sustained improvement in bone and cartilage turnover markers with the antiâinterleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone
- (2009) Patrick Garnero et al. ARTHRITIS AND RHEUMATISM
- Osteoclasts and Arthritis
- (2009) Georg Schett et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Management of cardiovascular disease risk in chronic inflammatory disorders
- (2009) Mariana J. Kaplan Nature Reviews Rheumatology
- Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production
- (2009) Misato Hashizume et al. RHEUMATOLOGY INTERNATIONAL
- IL-6/sIL-6R trans-signalling, but not TNF-α induced angiogenesis in a HUVEC and synovial cell co-culture system
- (2009) Misato Hashizume et al. RHEUMATOLOGY INTERNATIONAL
- Evidence of Systemic Inflammation and Estimation of Coronary Artery Disease Risk: A Population Perspective
- (2008) Peter W.F. Wilson AMERICAN JOURNAL OF MEDICINE
- Osteoclasts secrete non-bone derived signals that induce bone formation
- (2008) Morten A. Karsdal et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tocilizumab, a Humanized Anti-interleukin-6 Receptor Antibody, Ameliorates Joint Swelling in Established Monkey Collagen-Induced Arthritis
- (2008) Yasushi Uchiyama et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Autoantibody production in patients treated with anti-TNF-α
- (2008) Fabiola Atzeni et al. Expert Review of Clinical Immunology
- IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF- and IL-17
- (2008) M. Hashizume et al. RHEUMATOLOGY
- Systemic Nonarticular Manifestations of Rheumatoid Arthritis: Focus on Inflammatory Mechanisms
- (2008) Larry W. Moreland et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
- (2007) A Gonzalez et al. ANNALS OF THE RHEUMATIC DISEASES
- Chronic stress and regulation of cellular markers of inflammation in rheumatoid arthritis: Implications for fatigue
- (2007) Mary C. Davis et al. BRAIN BEHAVIOR AND IMMUNITY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started